Skip to main content
. 2018 Sep 27;136(12):1325–1333. doi: 10.1001/jamaophthalmol.2018.3881

Table 1. Tumor Features of Small Choroidal Melanoma Cases Managed With Plaque Radiotherapy (N = 1780).

Characteristic Patients Without Metastasis (n = 1689) Patients With Metastasis (n = 91) P Value Total (N = 1780) Relative Risk (95% CI) P Value
Tumor epicenter
Iris 0 0 >.99a 0
Ciliary body 29 (1.7) 1 (1) 30 (1.7) 1 [Reference] .48
Choroid 1660 (98.3) 90 (99) 1750 (98.3) 2.03 (0.28-14.6)
Tumor quadrant
Macula 518 (30.7) 23 (2) .35 541 (30.4) 1 [Reference] NA
Inferior 261 (15.5) 21 (23) 282 (15.8) 1.80 (1.00-3.25) .05
Temporal 308 (18.2) 14 (15) 322 (18.1) 1.08 (0.56-2.10) .82
Superior 389 (23.0) 22 (24) 411 (23.1) 1.29 (0.72-2.32) .39
Nasal 213 (12.6) 11 (12) 224 (12.6) 1.08 (0.52-2.21) .84
Anterior tumor margin
Macula 193 (11.4) 7 (8) .28 200 (11.2) 1 [Reference] NA
Macula to equator 1041 (61.6) 54 (59) 1095 (61.5) 1.38 (0.63-3.04) .42
Equator to ora 381 (22.6) 28 (31) 409 (23.0) 1.95 (0.85-4.46) .12
Ciliary body 54 (3.2) 2 (2) 56 (3.1) 0.96 (0.20-4.63) .96
Iris 20 (1).2 0 20 (1.1) NE .98
Posterior tumor margin
Macula 952 (56.4) 47 (52) .59 999 (56.1) 1 [Reference] NA
Macula to equator 679 (40.2) 41 (45) 720 (40.4) 1.22 (0.80 -1.86) .35
Equator to ora 42 (2.5) 3 (3) 45 (2.5) 1.11 (0.34-3.56) .87
Ciliary body 16 (0.9) 0 16 (0.9) NE .98
Iris 0 0 0 NE NA
Tumor largest basal diameter, mm
Mean (SD) 8.7 (2.9) 10.0 (3.4) <.001b 8.8 (2.9) 1.16c (1.09-1.24) <.001
Median (range) 8 (2-20) 10 (3-20) 8 (2-20)
Tumor thickness, mm
Mean (SD) 2.6 (0.5) 2.8 (0.5) .002b 2.6 (0.5) 2.41c (1.50-3.85) <.001
Median (range) 2.7 (0.2-3.4) 3.0 (0.5-3.4) 2.7 (0.2-3.4)
Distance to foveola, mm
Mean (SD) 3.4 (3.9) 3.7 (3.6) .42b 3.4 (3.9) 1.01c (0.96-1.06) .72
Median (range) 2 (0-21) 3 (0-14) 2 (0-21)
0-3 1074 (63.6) 51 (56) .15 1125 (63.2) 1 [Reference] NA
>3 615 (36.4) 40 (44) 655 (36.8) 1.23 (0.81-1.86) .33
Distance to optic nerve, mm
Mean (SD) 3.7 (3.7) 3.4 (3.2) .46b 3.7 (3.7) 1.03d (0.97-1.09) .41
Median (range) 3 (0-21) 3 (0-12) 3 (0-21)
0-3 964 (57.1) 49 (54) .55 1013 (56.9) 1 [Reference] NA
>3 725 (42.9) 42 (46) 767 (43.1) 1.08 (0.72-1.63) .72
Retinal detachment
None 334 (19.8) 10 (11) <.001 344 (19.3) 1 [Reference] NA
<3 mm 912 (54.0) 45 (50) 957 (53.8) 1.69 (0.85-3.36) .13
1 quadrant 362 (21.4) 23 (25) 385 (21.6) 2.55 (1.21-5.36) .01
2 quadrants 70 (4.1) 9 (10) 79 (4.4) 3.88 (1.58-9.56) .003
3 quadrants 10 (0.6) 4 (4) 14 (0.8) 9.70 (3.03-31.1) <.001
4 quadrants 1 (0.1) 0 1 (0.1) NE .99
Other clinical features
Diffuse 194 (11.5) 18 (20) .03a 212 (11.9) 1.83 (1.09-3.07) .02
Bruch rupture 40 (2.4) 2 (2) >.99a 42 (2.4) 1.08 (0.27-4.40) .91
Extraocular extension 12 (0.7) 0 >.99a 12 (0.7) NE .98
Retinal invasion 19 (1.1) 3 (3) .01a 22 (1.2) 2.47 (0.78-7.82) .12
Vitreous hemorrhage 18 (1.1) 1 (1) >.99a 19 (1.1) 1.67 (0.23-12.0) .61
Orange pigment 1042 (61.7) 47 (52) .06 1089 (61.2) 0.85 (0.57-1.29) .45
Drusen 375 (22.2) 15 (17) .24a 390 (21.9) 0.62 (0.36-1.08) .09
Halo 96 (5.7) 1 (1) .06a 97 (5.4) 0.23 (0.03-1.65) .14
Subfoveal fluid 524 (31.0) 26 (29) .73 550 (30.9) 0.88 (0.56-1.38) .57

Abbreviations: NA, not applicable; NE, not estimable.

a

By Fisher exact test.

b

By t test.

c

Per 1-mm increase.

d

Per 1-mm decrease.